FRANKLIN RESOURCES INC - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 166 filers reported holding BLUEBIRD BIO INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.

Quarter-by-quarter ownership
FRANKLIN RESOURCES INC ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q3 2023$59,128
-25.9%
19,450
-19.9%
0.00%
Q2 2023$79,842
+3.6%
24,268
+0.1%
0.00%
Q1 2023$77,067
-55.4%
24,235
-2.9%
0.00%
Q4 2022$172,772
+12.2%
24,967
+2.4%
0.00%
Q3 2022$154,000
-84.1%
24,389
-24.1%
0.00%
Q1 2021$968,000
-72.6%
32,116
-60.6%
0.00%
-100.0%
Q4 2020$3,530,000
-18.8%
81,584
+1.2%
0.00%
-50.0%
Q3 2020$4,348,000
-17.2%
80,591
+0.2%
0.00%
-33.3%
Q2 2020$5,253,000
+43.1%
80,411
+0.7%
0.00%
+50.0%
Q1 2020$3,671,000
-47.2%
79,884
+0.9%
0.00%
-50.0%
Q4 2019$6,950,000
-49.1%
79,200
-46.7%
0.00%
-42.9%
Q3 2019$13,654,000
-27.8%
148,7000.0%0.01%
-30.0%
Q2 2019$18,915,000
-19.1%
148,7000.0%0.01%
-23.1%
Q1 2019$23,395,000
+58.6%
148,7000.0%0.01%
+44.4%
Q4 2018$14,751,000
-73.6%
148,700
-61.2%
0.01%
-67.9%
Q3 2018$55,944,000
-8.2%
383,178
-1.3%
0.03%
-9.7%
Q2 2018$60,959,000
-6.4%
388,400
+1.8%
0.03%
-6.1%
Q1 2018$65,141,000
-46.8%
381,500
-44.5%
0.03%
-44.1%
Q4 2017$122,337,000
+83.3%
686,900
+41.3%
0.06%
+78.8%
Q3 2017$66,752,000
+30.7%
486,0000.0%0.03%
+32.0%
Q2 2017$51,054,000
-41.8%
486,000
-49.7%
0.02%
-44.4%
Q1 2017$87,782,000
+53.8%
965,700
+4.4%
0.04%
+50.0%
Q4 2016$57,091,000
-27.5%
925,300
-20.4%
0.03%
-26.8%
Q3 2016$78,749,000
+56.6%
1,161,8320.0%0.04%
+51.9%
Q2 2016$50,296,000
+22.6%
1,161,832
+20.3%
0.03%
+22.7%
Q1 2016$41,036,000
-16.5%
965,561
+26.1%
0.02%
-12.0%
Q4 2015$49,171,000
-20.1%
765,661
+6.4%
0.02%
-16.7%
Q3 2015$61,571,000
-47.9%
719,704
+2.5%
0.03%
-44.4%
Q2 2015$118,196,000
+115.5%
702,001
+54.6%
0.05%
+116.0%
Q1 2015$54,846,000
+39.4%
454,132
+5.9%
0.02%
+38.9%
Q4 2014$39,332,000
+140.2%
428,832
-6.0%
0.02%
+157.1%
Q3 2014$16,373,000
+25.4%
456,332
+34.8%
0.01%
+16.7%
Q2 2014$13,057,000
+69.6%
338,5320.0%0.01%
+50.0%
Q1 2014$7,698,000
+11.6%
338,532
+2.9%
0.00%
+33.3%
Q4 2013$6,899,000
-24.7%
328,832
-3.2%
0.00%
-40.0%
Q3 2013$9,156,000339,6320.01%
Other shareholders
BLUEBIRD BIO INC shareholders Q3 2023
NameSharesValueWeighting ↓
Monashee Investment Management LLC 125,000$13,131,0005.55%
Cormorant Asset Management, LP 275,000$28,889,0004.79%
Eventide Asset Management 569,700$59,847,0003.73%
Crosspoint Capital Strategies, LLC 28,937$3,040,0002.66%
Casdin Capital, LLC 65,000$6,828,0002.53%
ARK Investment Management 119,683$12,573,0002.45%
RTW INVESTMENTS, LP 104,383$10,965,0002.31%
Taylor Wealth Management Partners 38,368$4,031,0001.82%
First Light Asset Management, LLC 33,780$3,549,0001.19%
Atika Capital Management LLC 25,000$2,627,0000.92%
View complete list of BLUEBIRD BIO INC shareholders